AGNELLI, Giancarlo
 Distribuzione geografica
Continente #
NA - Nord America 17.720
EU - Europa 12.222
AS - Asia 11.395
SA - Sud America 2.234
Continente sconosciuto - Info sul continente non disponibili 1.042
AF - Africa 307
OC - Oceania 15
Totale 44.935
Nazione #
US - Stati Uniti d'America 17.278
SG - Singapore 5.592
UA - Ucraina 2.213
IE - Irlanda 2.158
RU - Federazione Russa 1.860
BR - Brasile 1.707
IT - Italia 1.653
CN - Cina 1.484
HK - Hong Kong 1.302
VN - Vietnam 1.245
SE - Svezia 963
DE - Germania 889
FR - Francia 724
FI - Finlandia 678
GB - Regno Unito 410
KR - Corea 286
IN - India 268
TR - Turchia 240
BD - Bangladesh 212
CA - Canada 205
AR - Argentina 162
IQ - Iraq 129
MX - Messico 118
AT - Austria 103
PL - Polonia 101
PK - Pakistan 90
EC - Ecuador 84
ZA - Sudafrica 83
NL - Olanda 82
CH - Svizzera 79
CO - Colombia 76
UZ - Uzbekistan 74
JP - Giappone 68
VE - Venezuela 67
ES - Italia 62
SA - Arabia Saudita 58
CL - Cile 53
BE - Belgio 52
ID - Indonesia 50
LB - Libano 46
PH - Filippine 41
MA - Marocco 40
LT - Lituania 38
TN - Tunisia 36
CZ - Repubblica Ceca 35
EG - Egitto 35
JO - Giordania 31
GR - Grecia 29
KE - Kenya 29
PY - Paraguay 27
JM - Giamaica 25
CR - Costa Rica 24
MY - Malesia 20
BO - Bolivia 19
AE - Emirati Arabi Uniti 18
UY - Uruguay 18
PE - Perù 16
KG - Kirghizistan 15
OM - Oman 14
AL - Albania 13
AZ - Azerbaigian 13
IL - Israele 13
RO - Romania 13
DZ - Algeria 12
PA - Panama 12
PS - Palestinian Territory 12
SK - Slovacchia (Repubblica Slovacca) 12
BG - Bulgaria 11
TH - Thailandia 11
ET - Etiopia 10
EU - Europa 10
NG - Nigeria 10
KZ - Kazakistan 9
NP - Nepal 9
TT - Trinidad e Tobago 9
HR - Croazia 7
SY - Repubblica araba siriana 7
AU - Australia 6
BH - Bahrain 6
CI - Costa d'Avorio 6
EE - Estonia 6
GT - Guatemala 6
HN - Honduras 6
KW - Kuwait 6
NI - Nicaragua 6
NZ - Nuova Zelanda 6
SN - Senegal 6
SV - El Salvador 6
XK - ???statistics.table.value.countryCode.XK??? 6
AO - Angola 5
DO - Repubblica Dominicana 5
GE - Georgia 5
GY - Guiana 5
LY - Libia 5
PR - Porto Rico 5
PT - Portogallo 5
SC - Seychelles 5
BY - Bielorussia 4
DK - Danimarca 4
KH - Cambogia 4
Totale 43.831
Città #
Singapore 3.839
Chandler 2.342
Dublin 2.147
San Jose 1.353
Hong Kong 1.291
San Mateo 1.222
Jacksonville 1.137
Ashburn 998
Boardman 751
Santa Clara 725
Dong Ket 681
Altamura 671
Moscow 645
Medford 581
Princeton 576
Lauterbourg 516
Lawrence 501
Des Moines 495
Wilmington 396
Ann Arbor 383
Andover 360
Perugia 358
Beijing 299
Seoul 284
Los Angeles 251
New York 224
Munich 219
Ho Chi Minh City 200
The Dalles 196
Saint Petersburg 174
São Paulo 158
Izmir 146
Helsinki 139
Hanoi 138
Piscataway 133
Norwalk 114
Shanghai 96
San Paolo di Civitate 93
Frankfurt am Main 79
Dallas 72
Chicago 69
Redmond 67
Brooklyn 66
Turku 66
Montreal 65
Rome 64
Tokyo 62
Nuremberg 59
Orem 58
Warsaw 54
Rio de Janeiro 53
Brussels 51
Houston 51
Baghdad 49
Chennai 49
Stockholm 46
Atlanta 44
Johannesburg 44
Boston 43
Phoenix 43
Belo Horizonte 40
Ottawa 40
Lahore 39
London 39
Woodbridge 39
Columbus 37
Denver 37
Dearborn 36
Falls Church 36
San Francisco 35
Brasília 34
Mexico City 34
Amsterdam 32
Buffalo 32
Hefei 32
Seattle 32
Toronto 32
Manchester 30
Jeddah 29
Redwood City 29
Tashkent 29
Mumbai 28
Philadelphia 28
Vienna 28
Amman 27
Charlotte 27
Da Nang 26
New Delhi 26
Ankara 25
Council Bluffs 25
Den Haag 25
Guangzhou 25
Poplar 25
Medellín 24
Milan 24
Nairobi 24
Guayaquil 23
Auburn Hills 20
Caracas 20
Dhaka 20
Totale 27.279
Nome #
Bedside sonography assessment of extravascular lung water increase after major pulmonary resection in non-small cell lung cancer patients 150
Systemic thrombolysis in patients with acute ischemic stroke and internal carotid artery occlusion: The ICARO study 150
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 145
Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model 142
A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: The @RISTOS Project 140
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 136
Aspirin for preventing the recurrence of venous thromboembolism. 136
Acute myocardial infarction and heart failure in acute stroke patients: frequency and influence on clinical outcome. 135
Anticoagulation after Stroke in Patients with Atrial Fibrillation: To Bridge or Not with Low-Molecular-Weight Heparin? 135
Arterial hypertension as risk factor for spontaneous cervical artery dissection. A case-control study 134
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 132
Acute stroke symptoms: Do differences exist between sexes? 130
Prestroke CHA2DS2-VASc Score and Severity of Acute Stroke in Patients with Atrial Fibrillation: Findings from RAF Study 127
Causes and Risk Factors of Cerebral Ischemic Events in Patients with Atrial Fibrillation Treated with Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention: The RENo Study 127
Angiographic findings of moyamoya vessels in a patient with rheumatoid arthritis 125
Epidemiology of cerebral vein and sinus thrombosis. 124
Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Effect of Anticoagulation and Its Timing: The RAF Study 123
Prognostic value of trans-thoracic echocardiography in patients with acute stroke and atrial fibrillation: findings from the RAF study 123
Hemorrhagic transformation in patients with acute ischemic stroke and atrial fibrillation: Time to initiation of oral anticoagulant therapy and outcomes 119
Early admission to stroke unit influences clinical outcome 118
[Spinal anesthesia and prophylaxis of venous thromboembolism. Results of a national survey]. 118
Acute hyperglycemia and early hemorrhagic transformation in ischemic stroke. 117
Severity of acute intracerebral haemorrhage, elderly age and atrial fibrillation: Independent predictors of poor outcome at three months 117
Alcohol intake and the risk of intracerebral hemorrhage in the elderly: The MUCH-Italy 116
Sex-related differences in risk factors, type of treatment received and outcomes in patients with atrial fibrillation and acute stroke: Results from the RAF-study (Early Recurrence and Cerebral Bleeding in Patients with Acute Ischemic Stroke and Atrial Fibrillation) 116
A Clinical Outcome-Based Prospective Study on Venous Thromboembolism After Cancer Surgery The @RISTOS Project 115
Secondary stroke prevention in women. 115
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 114
96 hours ECGmonitoring for patients with ischemic cryptogenic stroke or transient ischaemicattack. 113
Prediction of Early Recurrent Thromboembolic Event and Major Bleeding in Patients with Acute Stroke and Atrial Fibrillation by a Risk Stratification Schema: The ALESSA Score Study 112
A prospective study on cardiovascular events after acute pulmonary embolism 111
Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: the ICARO-2 study. 110
Atrial fibrillation in patients with first-ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome 110
Chemotherapy-associatedthromboembolic risk in cancer outpatients and effect of nadroparinthromboprophylaxis: results of a retrospective analysis of the PROTECHT study. 109
Predictive value of admission blood glucose level on short-term mortality in acute cerebral ischemia. 109
[Effect of platelet-derived growth factor on the in vitro cell proliferation of chick embryo skin]. 109
Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study 109
Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study. 108
Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: findings from the Global Orthopaedic Registry. 108
Definition of major bleeding: Prognostic classification 108
A new strategy for anticoagulation: The factor XI inhibitors 107
Dermatan sulphate for heparin-induced thrombocytopenia and central venous catheter related deep vein thrombosis in a child with acute lymphoblastic leukemia 107
Efficacy of thrombolytic (rt-PA) therapy in old stroke patients: the Perugia Stroke Unit experience 107
Acute pulmonary embolism: external validation of an integrated risk stratification model. 107
Acute pulmonary embolism: external validation of the 2014 risk stratification model of the European Society of Cardiology 107
Cancer-associated ischemic stroke: A retrospective multicentre cohort study 107
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 107
Patients aged 90  years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study 107
Anticoagulation for atrial fibrillation in patients with active cancer: Reply to the ‘Letter to the Editor’ from Dr. Sorigue et al 107
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism 106
A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer. 106
Lessons learned from the global orthopaedic registry: study design, current practice patterns, and future directions. 105
Is antithrombotic prophylaxis required in cancer patients with central venous catheters? No. 105
A sudden neurological deficit in a patient with endocarditis. 105
Admission Leukocytosis in Acute Cerebral Ischemia: Influence on Early Outcome. 105
Anticoagulation in patients with isolated distal deep vein thrombosis: a meta-analysis 105
Gene-drug interaction in stroke. 104
Venous thromboembolism associated with long-term use of central venous catheters in cancer patients 104
A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score. 104
[Acute immunoallergic thrombopenia due to sulfamethoxazole-trimethoprim]. 104
Risk factors for venous thromboembolism in the elderly: results of the master registry. 103
[Heparin in anesthesia. Pharmacological and clinical aspects in the prophylaxis of venous thromboembolism]. 103
A randomised, double-blind, placebo-controlled trial of dermatan sulphate for prevention of deep vein thrombosis in hip fracture. 103
Intravenous thrombolysis or endovascular therapy for acute ischemic stroke associated with cervical internal carotid artery occlusion: the ICARO-3 study 103
Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcme-based meta-analysis 103
Association of persistent right ventricular dysfunction at hospital discharge after acute pulmonary embolism with recurrent thromboembolic events 102
Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study. 102
Arterite temporale occulta: contributo casistico e revisione della letteratura 102
Cardiac hemangioma of the right atrium: a possible cause of cerebellar stroke. 102
Clinical skills or high-tech MR in TIA patients: what makes the difference? 102
Early recurrence and major bleeding in patients with acute ischemic stroke and atrial fibrillation treated with Non-Vitamin-K oral anticoagulants (RAF-NOACs) Study 102
Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation 102
Lacunar stroke syndromes as predictors of lacunar and non-lacunar infarcts on neuroimaging: a hospital-based study 102
Bosentan for chronic thromboembolic pulmonary hypertension: findings from a systematic review and meta-analysis. 102
Prevention of venous thromboembolism in surgical patients 101
Risk factors for adverse short-term outcome in patients with pulmonary embolism 101
Initial treatment of venous thromboembolism 101
Isolated monoparesis following stroke 101
Risk of recurrent venous thromboembolism after acute pulmonary embolism: Role of residual pulmonary obstruction and persistent right ventricular dysfunction. A meta-analysis 101
A prospective study on survival in cancer patients with and without venous thromboembolism. 101
Prevalence of thrombophilic genetic mutations in patients undergoing thrombotic events while on oral anticoagulants a case-control study 101
Sulodexide in the treatment of intermittent claudication. Results of a randomized, double-blind, multicentre, placebo-controlled study. 100
Heparin in anesthesia. Pharmacological and clinical aspects in the prophylaxis of venous thromboembolism 100
Are placebo-controlled trials ethical in areas where current guidelines recommend therapy? No 100
The good use of plasma. A critical analysis of five international guidelines. 100
Factors associated with the timing of diagnosis of venous thromboembolism: results from the MASTER registry. 100
Risk Profile of Symptomatic Lacunar Stroke Versus Nonlobar Intracerebral Hemorrhage 100
Pattern of in-hospital changes in drug use in the older people from 2010 to 2016 99
Risk factor for upper limb deep vein thrombosis 99
Acute pulmonary embolism. 99
Endothelial dysfunction in patients with spontaneous venous thromboembolism. 99
D-dimer for riskstratification in patients with acute pulmonary embolism. 99
[Determinants of prognosis in acute pulmonary embolism: the role of serum troponins]. 99
Acute pulmonary embolism: risk stratification in the emergency department. 99
[Prevention of venous thromboembolism in orthopedic surgery and traumatology]. 99
Cervical artery dissection: emerging risk factors. 99
Early recurrence in paroxysmal versus sustained atrial fibrillation in patients with acute ischaemic stroke 99
[Occult temporal arteritis. Case reports and review of the literature]. 99
Vascular cognitive impairment: a pragmatic concept 98
Dermatan sulphate in patients with heparin-induced thrombocytopenia. 98
Totale 11.036
Categoria #
all - tutte 219.972
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 219.972


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.393 0 780 64 153 232 31 46 1.540 68 167 469 843
2022/20238.339 663 1.638 121 542 651 1.170 21 340 2.832 23 264 74
2023/20242.458 205 309 189 40 47 22 475 123 164 119 427 338
2024/20256.653 52 714 151 240 924 326 179 510 1.438 429 1.052 638
2025/202614.241 1.217 868 729 1.822 1.870 1.244 2.582 741 1.472 1.148 350 198
2026/2027605 281 324 0 0 0 0 0 0 0 0 0 0
Totale 44.935